Acerus Announces Closing of US$15 Million Secured Loan Facility
April 30, 2021 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into a US$15 million...
Acerus Buys Back All Remaining U.S. Rights for NATESTO® From Aytu
April 01, 2021 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, April 01, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX: ASP, OTCQB: ASPCF) (“Acerus” or the “Company”), a specialty pharmaceutical company focused on the...
Acerus Announces Expansion of NATESTO® Distribution Worldwide
March 30, 2021 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX: ASP, OTCQB: ASPCF) (“Acerus” or the “Company”), a speciality pharmaceutical company focused on the...
Acerus Announces Amendment to Credit Agreement
March 26, 2021 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, March 26, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today announced that it has entered into an amended agreement...
Acerus Reports Fourth Quarter and Full Year 2020 Financial Results
March 11, 2021 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and...
Acerus to Report 2020 Financial Results and Host Investor Call
March 04, 2021 07:30 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its fourth quarter and full year 2020 financial and operating results on Thursday,...
Acerus Announces Voting Results for the 2018 Annual and Special Meeting
June 28, 2018 16:51 ET
|
Acerus Pharmaceuticals Corporation
TORONTO, June 28, 2018 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus”) (TSX:ASP) today announced the voting results from its annual and special meeting of shareholders held on June...
Acerus Pharmaceuticals Corporation Announces Closing of $6.61 Million Bought Deal Financing and Exercising of the Over-Allotment
June 28, 2018 09:42 ET
|
Acerus Pharmaceuticals Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, June 28,...
Acerus Pharmaceuticals Announces Upsize of its Previously Announced Bought Deal Financing to $5.75 Million
June 07, 2018 10:53 ET
|
Acerus Pharmaceuticals Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, June 07,...
Acerus Pharmaceuticals Corporation Announces $5 Million Bought Deal Financing
June 06, 2018 16:06 ET
|
Acerus Pharmaceuticals Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, June 06,...